Notably, FSCN1 associated with taxane-resistant expressed highly in single-cell subclonal populations in ARLow/mCRPC/NEPC prostate cancer (PC3, PC3M, and DU145; Fig. 1BV). This evidence concerns the gene FSCN1 and prostate carcinoma.